Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia

被引:68
作者
Bah, Amat [1 ]
Pasricha, Sant-Rayn [2 ]
Jallow, Momodou W. [1 ]
Sise, Ebrima A. [1 ]
Wegmuller, Rita [1 ]
Armitage, Andrew E. [2 ]
Drakesmith, Hal [2 ]
Moore, Sophie E. [3 ]
Prentice, Andrew M. [4 ,5 ]
机构
[1] Gambia MRC Int Nutr Grp, Med Res Council MRC Unit, Banjul, Gambia
[2] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England
[3] Kings Coll London, Div Womens Hlth, London, England
[4] Gambia MRC Int Nutr Grp, MRC Unit, London, England
[5] London Sch Hyg & Trop Med, London, England
基金
英国医学研究理事会;
关键词
hepcidin; anemia; iron deficiency; pregnancy; diagnostic; RANDOMIZED CONTROLLED-TRIAL; RURAL GAMBIA; WOMEN; SUPPLEMENTATION; HOMEOSTASIS; INFECTION; ANEMIA; SCREEN; IDENTIFICATION; POPULATION;
D O I
10.3945/jn.116.245373
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Antenatal anemia is a risk factor for adverse maternal and fetal outcomes and is prevalent in sub-Saharan Africa. Less than half of antenatal anemia is considered responsive to iron; identifying women in need of iron may help target interventions. Iron absorption is governed by the iron-regulatory hormone hepcidin. Objective: We sought to characterize changes in hepcidin and its associations with indexes of iron stores, erythropoiesis, and inflammation at weeks 14, 20, and 30 of gestation and to assess hepcidin's diagnostic potential as an index of iron deficiency. Methods: We measured hemoglobin and serum hepcidin, ferritin, soluble transferrin receptor (sTfR), and C-reactive protein (CRP) at 14, 20, and 30 wk of gestation in a cohort of 395 Gambian women recruited to a randomized controlled trial. Associations with hepcidin were measured by using linear regression, and hepcidin's diagnostic test accuracy [area under the receiver operating characteristic curve (AUC(ROC)), sensitivity, specificity, cutoffs] for iron deficiency at each time point was analyzed. Results: The prevalence of anemia increased from 34.6% at 14 wk of gestation to 50.0% at 20 wk. Hepcidin concentrations declined between study enrollment and 20 wk, whereas ferritin declined between 20 and 30 wk of gestation. The variations in hepcidin explained by ferritin, sTfR, and CRP declined over pregnancy. The AUC(ROC) values for hepcidin to detect iron deficiency (defined as ferritin <15 mu g/L) were 0.86, 0.83, and 0.84 at 14, 20, and 30 wk, respectively. Hepcidin was superior to hemoglobin and sTfR as an indicator of iron deficiency. Conclusions: In Gambian pregnant women, hepcidin appears to be a useful diagnostic test for iron deficiency and may enable the identification of cases for whom iron would be beneficial. Hepcidin suppression in the second trimester suggests a window for optimal timing for antenatal iron interventions. Hemoglobin does not effectively identify iron deficiency in pregnancy.
引用
收藏
页码:1131 / 1137
页数:7
相关论文
共 45 条
[1]   Pregnancy and Laboratory Studies A Reference Table for Clinicians [J].
Abbassi-Ghanavati, Mina ;
Greer, Laura G. ;
Cunningham, F. Gary .
OBSTETRICS AND GYNECOLOGY, 2009, 114 (06) :1326-1331
[2]  
[Anonymous], 2008, WHO global database on anemia
[3]  
[Anonymous], 2002, WORLD HLTH REP RED R
[4]  
[Anonymous], 2015, GLOB PREV AN 2011
[5]  
[Anonymous], 2011, Serum ferritin concentrations to assess iron nutrition status in individuals and populations: technical report internet
[6]  
[Anonymous], 2001, Iron Deficiency Anemia. Assessment, P1
[7]  
[Anonymous], Daily Iron and Folic Acid Supplementation during Pregnancy
[8]   A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron [J].
Bah, Amat ;
Wegmuller, Rita ;
Cerami, Carla ;
Kendall, Lindsay ;
Pasricha, Sant-Rayn ;
Moore, Sophie E. ;
Prentice, Andrew M. .
BMC PREGNANCY AND CHILDBIRTH, 2016, 16
[9]  
Bothwell TH, 2000, AM J CLIN NUTR, V72, p257S, DOI 10.1093/ajcn/72.1.257S
[10]  
Byg Keld-Erik, 2000, Hematology, V5, P319